RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

A private donation from Sally Cahill, USA, to researchers at Karolinska Institutet could make a new treatment for severe rheumatoid arthritis a ...

BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.

ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b trial enrolling approximately 180 patients across nine ...

Morning stiffness from rheumatoid arthritis can make it hard to get going. Try this morning routine to start your day right.

Elevara Medicines has dosed the first patient in its phase 2b START-SYNERGY trial, marking a key step in the development of ELV001, an oral CDK4/6 inhibitor being studied for rheumatoid arthritis in ...

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...

Surf Therapeutics, a clinical-stage company developing non-invasive ultrasound neuromodulation therapies to treat ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organisations ...